121 related articles for article (PubMed ID: 2964111)
1. Selective inhibition of the canine mixed lymphocyte response by HLA-DR and DP-reactive monoclonal antibodies.
Ladiges WC; Pesando JM; Severns E; Longton G; Deeg HJ; Storb R
Transplantation; 1988 Feb; 45(2):484-8. PubMed ID: 2964111
[TBL] [Abstract][Full Text] [Related]
2. Comparative reactivity of anti-Ia monoclonal antibodies in man and laboratory animals.
Ladiges WC; Severns E; Pesando JM
Hybridoma; 1988 Oct; 7(5):465-70. PubMed ID: 2974014
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
4. Recognition of major histocompatibility complex class II antigens by two anti-HLA-DR monoclonal antibodies on canine marrow cells correlates with effects on in vitro and in vivo hematopoiesis.
Yamaguchi M; McSweeney PA; Kimball L; Gersuk G; Hong DS; Kwok W; Storb R; Beckham C; Deeg HJ
Transplantation; 1999 Oct; 68(8):1161-71. PubMed ID: 10551646
[TBL] [Abstract][Full Text] [Related]
5. Monocytes are differentially activated through HLA-DR, -DQ, and -DP molecules via mitogen-activated protein kinases.
Matsuoka T; Tabata H; Matsushita S
J Immunol; 2001 Feb; 166(4):2202-8. PubMed ID: 11160273
[TBL] [Abstract][Full Text] [Related]
6. Influence of HLA-DP mismatches on primary MLR responses in unrelated HLA-A, B, DR, DQ, Dw identical pairs in allogeneic bone marrow transplantation.
Cesbron A; Moreau P; Milpied N; Muller JY; Harousseau JL; Bignon JD
Bone Marrow Transplant; 1990 Nov; 6(5):337-40. PubMed ID: 1981326
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma.
van Vreeswijk H; Ruiter DJ; Bröcker EB; Welvaart K; Ferrone S
J Invest Dermatol; 1988 May; 90(5):755-60. PubMed ID: 3283252
[TBL] [Abstract][Full Text] [Related]
8. Both HLA-DR and HLA-DQ determinants contribute to HLA-Dw typing.
Sterkers G; Zeliszewski D; Freidel AC; Gebuhrer L; Betuel H; Levy JP
Hum Immunol; 1987 Nov; 20(3):233-47. PubMed ID: 2449409
[TBL] [Abstract][Full Text] [Related]
9. Detection of antibodies specific for HLA-A,B,C,DR,DQ and DP by the erythrocyte antibody rosette inhibition (EAI) and immune phagocytosis inhibition (IPI) tests.
Faust A; Neppert J
J Immunol Methods; 1987 Aug; 102(1):71-5. PubMed ID: 3476673
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies that distinguish between class II antigens (HLA-DP, DQ, and DR) in 14 haplotypes.
Robbins PA; Evans EL; Ding AH; Warner NL; Brodsky FM
Hum Immunol; 1987 Apr; 18(4):301-13. PubMed ID: 3494718
[TBL] [Abstract][Full Text] [Related]
11. Differential MHC class II expression on human peripheral blood monocytes and dendritic cells.
Brooks CF; Moore M
Immunology; 1988 Feb; 63(2):303-11. PubMed ID: 3350576
[TBL] [Abstract][Full Text] [Related]
12. Differential tissue distribution of HLA-DR, -DP and -DQ antigens.
Forsum U; Claesson K; Jonsson R; Karlsson-Parra A; Klareskog L; Scheynius A; Tjernlund U
Adv Exp Med Biol; 1987; 216A():233-9. PubMed ID: 3687525
[No Abstract] [Full Text] [Related]
13. Dissection of suppressor cell generation in vitro.
Pawelec G; Schneider EM; Rehbein A; Balko I; Wernet P
Hum Immunol; 1986 Nov; 17(3):343-54. PubMed ID: 2947883
[TBL] [Abstract][Full Text] [Related]
14. HLA-DR beta III and HLA-DP induce comparable proliferation in primary mixed lymphocyte culture.
Schroeijers WE; de Koster HS; van Rood JJ; Termijtelen A
Tissue Antigens; 1988 Sep; 32(3):145-9. PubMed ID: 2464203
[TBL] [Abstract][Full Text] [Related]
15. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
[TBL] [Abstract][Full Text] [Related]
16. Characterization of monoclonal antibodies directed against HLA class II molecules.
Cabrera T; Ruiz-Cabello F; Lopez MA; de la Higuera B; Sanchez M; Garrido F
Hybridoma; 1986; 5(3):191-7. PubMed ID: 3770773
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules.
Klohe EP; Watts R; Bahl M; Alber C; Yu WY; Anderson R; Silver J; Gregersen PK; Karr RW
J Immunol; 1988 Sep; 141(6):2158-64. PubMed ID: 2459201
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
Pesando JM; Graf L
J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
[TBL] [Abstract][Full Text] [Related]
19. Expression of HLA-A,B,C, beta 2-microglobulin (beta 2m), HLA-DR, -DP, -DQ and of HLA-D-associated invariant chain (Ii) in soft-tissue tumors.
Mechtersheimer G; Staudter M; Majdic O; Dörken B; Moldenhauer G; Möller P
Int J Cancer; 1990 Nov; 46(5):813-23. PubMed ID: 2228310
[TBL] [Abstract][Full Text] [Related]
20. Detection of HLA-DP serological allodeterminants by the use of radioiodinated DP molecules.
Tanigaki N; Tosi R; Parodi B; Sorrentino R; Ferrara GB; Strominger JL
Eur J Immunol; 1987 Jun; 17(6):743-50. PubMed ID: 2439347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
